TransMedics to Release Q4 and Full Year 2023 Financial Results
TransMedics Group, Inc., a medical technology company specializing in organ transplant therapy, is set to announce its financial results for the fourth quarter and full year of 2023. The disclosure will take place shortly after the market closes on February 26, 2024. Interested parties can participate in a conference call scheduled for the same day at 4:30 p.m. ET, where the earnings report will be discussed. This call welcomes both domestic and international investors.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
